| Product Code: ETC7548974 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India non-Hodgkin lymphoma market import shipments demonstrated a steady growth trend with a CAGR of 3.0 from 2020 to 2024. Notably, there was a significant acceleration in growth between 2023 and 2024, reflecting a robust upward momentum. Overall, the market expanded consistently over the period, indicating increasing demand for these imports.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Non Hodgkin Lymphoma Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Non Hodgkin Lymphoma Market Revenues & Volume, 2021 & 2031F |
3.3 India Non Hodgkin Lymphoma Market - Industry Life Cycle |
3.4 India Non Hodgkin Lymphoma Market - Porter's Five Forces |
3.5 India Non Hodgkin Lymphoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Non Hodgkin Lymphoma Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Non Hodgkin Lymphoma Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Non Hodgkin Lymphoma Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Non Hodgkin Lymphoma Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Non Hodgkin Lymphoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-Hodgkin lymphoma in India |
4.2.2 Advancements in diagnostic technologies and treatment options |
4.2.3 Growing healthcare infrastructure and access to healthcare services |
4.3 Market Restraints |
4.3.1 High treatment costs and limited insurance coverage |
4.3.2 Lack of awareness about non-Hodgkin lymphoma among the general population |
4.3.3 Challenges in early diagnosis and detection of non-Hodgkin lymphoma |
5 India Non Hodgkin Lymphoma Market Trends |
6 India Non Hodgkin Lymphoma Market, By Types |
6.1 India Non Hodgkin Lymphoma Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Non Hodgkin Lymphoma Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Non Hodgkin Lymphoma Market Revenues & Volume, By B-Cell Lymphomas, 2021- 2031F |
6.1.4 India Non Hodgkin Lymphoma Market Revenues & Volume, By T-Cell Lymphoma, 2021- 2031F |
6.2 India Non Hodgkin Lymphoma Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Non Hodgkin Lymphoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 India Non Hodgkin Lymphoma Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.2.4 India Non Hodgkin Lymphoma Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Non Hodgkin Lymphoma Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Non Hodgkin Lymphoma Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Non Hodgkin Lymphoma Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Non Hodgkin Lymphoma Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Non Hodgkin Lymphoma Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Non Hodgkin Lymphoma Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Non Hodgkin Lymphoma Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Non Hodgkin Lymphoma Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 India Non Hodgkin Lymphoma Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Non Hodgkin Lymphoma Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Non Hodgkin Lymphoma Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Non Hodgkin Lymphoma Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 India Non Hodgkin Lymphoma Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Non Hodgkin Lymphoma Market Import-Export Trade Statistics |
7.1 India Non Hodgkin Lymphoma Market Export to Major Countries |
7.2 India Non Hodgkin Lymphoma Market Imports from Major Countries |
8 India Non Hodgkin Lymphoma Market Key Performance Indicators |
8.1 Survival rates of non-Hodgkin lymphoma patients in India |
8.2 Adoption rate of novel therapies for non-Hodgkin lymphoma |
8.3 Number of research and development initiatives focused on non-Hodgkin lymphoma in India |
9 India Non Hodgkin Lymphoma Market - Opportunity Assessment |
9.1 India Non Hodgkin Lymphoma Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Non Hodgkin Lymphoma Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Non Hodgkin Lymphoma Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Non Hodgkin Lymphoma Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Non Hodgkin Lymphoma Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Non Hodgkin Lymphoma Market - Competitive Landscape |
10.1 India Non Hodgkin Lymphoma Market Revenue Share, By Companies, 2024 |
10.2 India Non Hodgkin Lymphoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here